Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction

Author(s): Sun D, Bu L, Liu C, Yin Z, Zhou X, et al.

Abstract

Interstitial fibrosis is regarded as the main pathway for the progression of chronic kidney disease (CKD) and is often associated with severe renal dysfunction. Stem cell-based therapies may provide alternative approaches for the treatment of CKD. Human amniotic fluid-derived stem cells (hAFSCs) are a novel stem cell population, which exhibit both embryonic and mesenchymal stem cell characteristics. Herein, the present study investigated whether the transplantation of hAFSCs into renal tissues could improve renal interstitial fibrosis in a murine model of unilateral ureteral obstruction (UUO). We showed that hAFSCs provided a protective effect and alleviated interstitial fibrosis as reflected by an increase in microvascular density; additionally, hAFSCs treatment beneficially modulated protein levels of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1α (HIF-1α) and transforming growth factor-β1 (TGF-β1). Therefore, we hypothesize that hAFSCs could represent an alternative, readily available source of stem cells that can be applied for the treatment of renal interstitial fibrosis.

Similar Articles

Mesenchymal stem cells reduce intervertebral disc fibrosis and facilitate repair

Author(s): Leung VYL, Aladin DMK, Lv F, Tam V, Sun Y, et al.

Injection of amniotic fluid stem cells delays progression of renal fibrosis

Author(s): Sedrakyan S, Da Sacco S, Milanesi A, Shiri L, Petrosyan A, et al.

Human amniotic fluid stem cells protect rat lungs exposed to moderate hyperoxia

Author(s): Grisafi D, Pozzobon M, Dedja A, Vanzo V, Tomanin R, et al.

Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury

Author(s): Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, et al.

Human amnion epithelial cells repair established lung injury

Author(s): Vosdoganes P, Wallace EM, Chan ST, Acharya R, Moss TJM, et al.

Human Wharton’s jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds

Author(s): Fong CY, Tam K, Cheyyatraivendran S, Gan SU, Gauthaman K, et al.

Human Wharton’s jelly mesenchymal stem cells promote skin wound healing through paracrine signaling

Author(s): Arno AI, Amini-Nik S, Blit PH, Al-Shebab M, Belo C, et al.

Fetal wound healing: implications for minimal scar formation

Author(s): Leung A, Crombleholme TM, Keswani SG

The role of stem cells during scarless wound healing

Author(s): Hu MS, Rennert RC, McArdle A, Chung MT, Walmsley GG, et al.

Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds

Author(s): Skardal A, Mack D, Kapetanovic E, Atala A, Jackson JD, et al.

Regulation of collagen synthesis by ascorbic acid

Author(s): Murad S, Grove D, Lindberg KA, Reynolds G, Sivarajah A, et al.

Effects of l-ascorbic acid 2-phosphate magnesium salt on the properties of human gingival fibroblasts

Author(s): Tsutsumi K, Fujikawa H, Kaijkawa T, Takedachi M, Yamamoto T, et al.

Identification of PLOD2 as telopeptidelysyl hydroxylase, an important enzyme in fibrosis

Author(s): van der Slot AJ, Zuurmond A, Bardoel AFJ, Wijmenga C, Pruijs HEH, et al.

Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells

Author(s): Pornprasertsuk S, Duarte WR, Mochida Y, Yamauchi M

The type of collagen cross-link determines the reversibility of experimental skin fibrosis

Author(s): van der Slot AJ, van Dura EA, Attema J, Blauw B, DeGroot J, et al.

Scarless wound healing in the mammalian fetus

Author(s): Mast BA, Diegelmann RF, Krummel TM, Cohen IK

Adult skin wounds in the fetal environment heal with scar formation

Author(s): Longaker MT, Whitby DJ, Ferguson MWJ, Lorenz HP, Harrison MR, et al.